Search Results

CDK4/CDK6 inhibitors synergize with Midostaurin, Avapritinib, and Nintedanib in inducing growth inhibition in KIT D816V+ neoplastic mast cells by Schneeweiss-Gleixner, Mathias (Author) , Filik, Yüksel (Author) , Stefanzl, Gabriele (Author) , Berger, Daniela (Author) , Sadovnik, Irina (Author) , Bauer, Karin (Author) , Smiljkovic, Dubravka (Author) , Eisenwort, Gregor (Author) , Witzeneder, Nadine (Author) , Greiner, Georg (Author) , Hoermann, Gregor (Author) , Schiefer, Ana-Iris (Author) , Schwaab, Juliana (Author) , Jawhar, Mohamad (Author) , Reiter, Andreas (Author) , Sperr, Wolfgang R. (Author) , Arock, Michel (Author) , Valent, Peter (Author) , Gleixner, Karoline V. (Author) ,

• lizenzpflichtig

Drug-induced mast cell eradication: a novel approach to treat mast cell activation disorders? by Valent, Peter (Author) , Akin, Cem (Author) , Hartmann, Karin (Author) , Reiter, Andreas (Author) , Gotlib, Jason (Author) , Sotlar, Karl (Author) , Sperr, Wolfgang R. (Author) , Degenfeld-Schonburg, Lina (Author) , Smiljkovic, Dubravka (Author) , Triggiani, Massimo (Author) , Horny, Hans-Peter (Author) , Arock, Michel (Author) , Galli, Stephen J. (Author) , Metcalfe, Dean D. (Author) ,

• lizenzpflichtig
• lizenzpflichtig

MPN-395: efficacy and safety of ≤200 mg avapritinib in patients with advanced systemic mastocytosis: pooled results from the phase 1 EXPLORER and interim phase 2 PATHFINDER studies... by Radia, Deepti (Author) , DeAngelo, Daniel (Author) , Deininger, Michael W. (Author) , Reiter, Andreas (Author) , Sen, Jayita (Author) , Lin, Hui Min (Author) , Dimitrijevic, Sasa (Author) , Gotlib, Jason (Author) ,

• lizenzpflichtig
• lizenzpflichtig